Exane Derivatives’s Avis CAR Stock Holding History

Exane Derivatives’s Portfolio CAR Stock Details CAR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-3,759	Closed	-$106K	–	688
2019 Q3	$106K	Hold	3,759	–	–	0.02%	310
2019 Q2	$132K	Buy	+3,759	New	+$126K	0.02%	295
2018 Q4	–	Sell	-2,865	Closed	-$91.8K	–	688
2018 Q3	$91.8K	Buy	+2,865	New	+$95.6K	0.02%	329

Other funds holding CAR

SIM

SRS Investment Management New York $9.47B AUM 60.12% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

LAM

Lyrical Asset Management New York $6.56B AUM 20.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Exane Derivatives's CAR Position: Q4 2019 in Review

Exane Derivatives sold out of Avis (CAR) in Q4 2019, closing a stake of 3,759 shares — an estimated $106K sold.

Exane Derivatives first reported a position in CAR in Q3 2018 and held it in 3 quarters. The position peaked at $132K in Q2 2019. 223 funds tracked by Wall St. Rank hold CAR as of Q4 2019.

Exane Derivatives reported no remaining Avis position as of Q4 2019 after selling out during the quarter.
Exane Derivatives sold 3,759 Avis shares in Q4 2019, an estimated $106K.
Exane Derivatives first reported a position in Avis in Q3 2018 and held it in 3 quarters.
Exane Derivatives's Avis position peaked at $132K in Q2 2019.
223 funds tracked by Wall St. Rank held Avis as of Q4 2019.

Based on Exane Derivatives's 13F filing for Q4 2019, filed 22 Jan 2020.